Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.

de Vries RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, van Trierum SE, Pronk MR, Lamers MM, Richard M, Nieuwenhuijse DF, Koopmans MPG, Kreijtz JHCM, Fouchier RAM, Osterhaus ADME, Sutter G, Rimmelzwaan GF.

J Infect Dis. 2018 Jul 13;218(4):614-623. doi: 10.1093/infdis/jiy214.

2.

H1N1pdm09 Influenza Virus and Its Descendants Lack Extra-epitopic Amino Acid Residues Associated With Reduced Recognition by M158-66-Specific CD8+ T Cells.

van de Sandt CE, Sagong KA, Pronk MR, Bestebroer TM, Spronken MI, Koopmans MPG, Fouchier RAM, Rimmelzwaan GF.

J Infect Dis. 2018 Jul 13;218(4):581-585. doi: 10.1093/infdis/jiy218.

3.

Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M158-66 Epitope-Specific CD8+ T Lymphocytes.

van de Sandt CE, Pronk MR, van Baalen CA, Fouchier RAM, Rimmelzwaan GF.

J Virol. 2018 May 14;92(11). pii: e00232-18. doi: 10.1128/JVI.00232-18. Print 2018 Jun 1.

4.

Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage.

van de Sandt CE, Dou Y, Vogelzang-van Trierum SE, Westgeest KB, Pronk MR, Osterhaus AD, Fouchier RA, Rimmelzwaan GF, Hillaire ML.

J Gen Virol. 2015 Aug;96(8):2061-73. doi: 10.1099/vir.0.000156. Epub 2015 Apr 21.

Supplemental Content

Loading ...
Support Center